ARTICLE | Company News
Byron Biopharma, Cel-Sci deal
March 22, 2010 7:00 AM UTC
Cel-Sci granted Byron exclusive rights to commercialize Multikine in South Africa. Byron paid Cel-Sci a $125,000 licensing fee and will be responsible for obtaining regulatory approval in the territo...